Literature DB >> 20865824

HLA-F is a surface marker on activated lymphocytes.

Ni Lee1, Akiko Ishitani, Daniel E Geraghty.   

Abstract

Of the three nonclassical class I antigens expressed in humans, HLA-F has been least characterized with regard to expression or function. In this study, we examined HLA-F expression focusing on lymphoid cells, where our previous work with homologous cell lines had demonstrated surface HLA-F expression. HLA-F protein expression was observed by Western blot analysis in all resting lymphocytes, including B cells, T cells, NK cells, and monocytes, all of which lacked surface expression in the resting state. Upon activation, using a variety of methods to activate different lymphocyte subpopulations, all cell types that expressed HLA-F intracellularly showed an induction of surface HLA-F protein. An examination of peripheral blood from individuals genetically deficient for TAP and tapasin expression demonstrated the same activation expression profiles for HLA-F,but with altered kinetics post-activation. Further analysis of CD41+CD25+1 Treg showed that HLA-F was not upregulated on the major fraction of these cells when they were activated,whereas CD41+CD25- T cells showed strong expression of surface HLA-F when activated under identical conditions. These findings are discussed with regard to possible functions for HLA-F and its potential clinical use as a marker of an activated immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865824      PMCID: PMC3867582          DOI: 10.1002/eji.201040348

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  45 in total

1.  Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.

Authors:  C Bonini; S P Lee; S R Riddell; P D Greenberg
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination.

Authors:  Hiroyoshi Nishikawa; Feng Qian; Takemasa Tsuji; Gerd Ritter; Lloyd J Old; Sacha Gnjatic; Kunle Odunsi
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

Review 3.  Spotlight on anti-CD25: daclizumab in MS.

Authors:  Dr Sven Schippling; Roland Martin
Journal:  Int MS J       Date:  2008-09

4.  Biochemical characterization of CD1d expression in the absence of beta2-microglobulin.

Authors:  H S Kim; J Garcia; M Exley; K W Johnson; S P Balk; R S Blumberg
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

5.  Prenatal tolerance--a role for regulatory T cells?

Authors:  Ana Izcue; Fiona Powrie
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

6.  Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.

Authors:  Paul J Martin; Ji Pei; Ted Gooley; Claudio Anasetti; Frederick R Appelbaum; Joachim Deeg; John A Hansen; Richard A Nash; Effie W Petersdorf; Rainer Storb; Victor Ghetie; John Schindler; Ellen S Vitetta
Journal:  Biol Blood Marrow Transplant       Date:  2004-08       Impact factor: 5.742

7.  Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.

Authors:  D A Shackelford; J L Strominger
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases.

Authors:  Y Sasaki; M Sakai; S Miyazaki; S Higuma; A Shiozaki; S Saito
Journal:  Mol Hum Reprod       Date:  2004-03-02       Impact factor: 4.025

9.  Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function.

Authors:  Manjula Reddy; Edward Eirikis; Cuc Davis; Hugh M Davis; Uma Prabhakar
Journal:  J Immunol Methods       Date:  2004-10       Impact factor: 2.303

10.  Selective export of HLA-F by its cytoplasmic tail.

Authors:  Louise H Boyle; Alison K Gillingham; Sean Munro; John Trowsdale
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

View more
  41 in total

1.  HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.

Authors:  Jodie P Goodridge; Ni Lee; Aura Burian; Chul-Woo Pyo; Scott S Tykodi; Edus H Warren; Cassian Yee; Stanley R Riddell; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

2.  Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma.

Authors:  Jian Zhang; Lelin Pan; Luyan Chen; Xiaowen Feng; Lin Zhou; Shusen Zheng
Journal:  Immunogenetics       Date:  2011-10-21       Impact factor: 2.846

3.  HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-09-09       Impact factor: 5.422

4.  HLA-Fatal attraction.

Authors:  Frédéric Vély; Rachel Golub; Eric Vivier
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

5.  Genome-wide pathway analysis of a genome-wide association study on psoriasis and Behcet's disease.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2011-12-27       Impact factor: 2.316

6.  Integrative analysis for identification of shared markers from various functional cells/tissues for rheumatoid arthritis.

Authors:  Wei Xia; Jian Wu; Fei-Yan Deng; Long-Fei Wu; Yong-Hong Zhang; Yu-Fan Guo; Shu-Feng Lei
Journal:  Immunogenetics       Date:  2016-11-03       Impact factor: 2.846

Review 7.  Roles for major histocompatibility complex glycosylation in immune function.

Authors:  Sean O Ryan; Brian A Cobb
Journal:  Semin Immunopathol       Date:  2012-03-30       Impact factor: 9.623

8.  HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.

Authors:  Zahra Kiani; Julie Bruneau; Daniel E Geraghty; Nicole F Bernard
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

Review 9.  Structural insights into activation of antiviral NK cell responses.

Authors:  Kathryn A Finton; Roland K Strong
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

10.  Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.

Authors:  V Jucaud; M H Ravindranath; P I Terasaki; L E Morales-Buenrostro; F Hiepe; T Rose; R Biesen
Journal:  Clin Exp Immunol       Date:  2015-12-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.